Titan Medical Inc. (NASDAQ:TMDI) is on recovery track with 128.58% gain from a 1-year low price of $1.05. The company lost -5.32% to attain the price of $2.4 on 6/3/2019. Throughout the recent session, the prices were hovering between $2.3781 and $2.64. These shares are -100% up from its target price of $0 and the current market capitalization stands at $52.02M. The recent change has given its price a -9.43% deficit over SMA 50 and -69.03% deficit over its 52-week high. The stock witnessed -16.08% declines, -44.05% declines and 21.83% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found TMDI’s volatility during a week at 7.89% and during a month it has been found around 7.76%.Titan Medical Inc. (TMDI) Top Holders
Institutional investors currently hold around $7 million or 0% in TMDI stock. Look at its top three institutional owners: Masters Capital Management Llc owns $3.17 million in Titan Medical Inc., which represents roughly 6.09% of the company’s market cap and approximately 45.27% of the institutional ownership. Similar statistics are true for the second largest owner, Cvi Holdings, Llc, which owns 762,371 shares of the stock are valued at $1.93 million. The third largest holder is Anson Funds Management Lp, which currently holds $792 thousand worth of this stock and that ownership represents nearly 1.52% of its market capitalization.
At the end of March reporting period, 18 institutional holders increased their position in Titan Medical Inc. (NASDAQ:TMDI) by some 1,503,457 shares, 12 decreased positions by 709,703 and 18 held positions by 634,901. That puts total institutional holdings at 2,848,061 shares, according to SEC filings. The stock grabbed 8 new institutional investments totaling 1,208,703 shares while 6 institutional investors sold out their entire positions totaling 679,474 shares.
Titan Medical Inc., a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the SPORT Surgical System, a single-port robotic surgical system that comprises a surgeon-controlled patient cart, which includes a 3D vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient’s body during MIS procedures.